Digestive & Intestinal Remedies (Pharmacies) - Central & Western Europe

  • Central & Western Europe
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$2.17bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 2.76%, resulting in a market volume of US$2.42bn by 2028.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$6.46 are generated in 2024.

Key regions: United States, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Central & Western Europe is experiencing steady growth due to several factors. Customer preferences for natural and herbal remedies, increasing awareness about digestive health, and the rising prevalence of digestive disorders are driving the demand for these products. Additionally, local special circumstances and underlying macroeconomic factors are also contributing to the market's development. Customer preferences in Central & Western Europe are shifting towards natural and herbal remedies for digestive issues. Consumers are becoming more conscious about the ingredients they consume and are seeking products that are perceived to be safer and more gentle on their bodies. This trend is evident in the growing popularity of herbal teas, probiotics, and dietary supplements that promote digestive health. The demand for these products is further fueled by the belief that natural remedies have fewer side effects compared to conventional medications. Another factor driving the growth of the Digestive & Intestinal Remedies market in Central & Western Europe is the increasing awareness about digestive health. People are becoming more educated about the importance of maintaining a healthy digestive system and are actively seeking ways to improve it. This awareness has led to a rise in preventive measures such as dietary changes, regular exercise, and the use of digestive health products. As a result, the demand for Digestive & Intestinal Remedies has seen a significant increase. The prevalence of digestive disorders in Central & Western Europe is also contributing to the growth of the market. Conditions such as irritable bowel syndrome, acid reflux, and gastritis are becoming more common in the region. The need for effective remedies to manage these conditions has created a lucrative market for Digestive & Intestinal Remedies. Consumers are actively seeking products that can alleviate their symptoms and improve their overall digestive health. In addition to customer preferences, there are also local special circumstances that are influencing the development of the Digestive & Intestinal Remedies market in Central & Western Europe. For example, the aging population in many countries in the region is driving the demand for products that address age-related digestive issues. Furthermore, the high prevalence of stress and unhealthy lifestyle habits in urban areas is also contributing to the market's growth. Underlying macroeconomic factors such as increasing disposable income and healthcare expenditure are also playing a role in the development of the market. As people have more financial resources, they are more willing to invest in their health and well-being. This includes purchasing Digestive & Intestinal Remedies to manage their digestive health. Additionally, the growing healthcare infrastructure in Central & Western Europe is making these products more accessible to consumers, further driving the market's growth. Overall, the Digestive & Intestinal Remedies (Pharmacies) market in Central & Western Europe is experiencing growth due to customer preferences for natural remedies, increasing awareness about digestive health, the rising prevalence of digestive disorders, local special circumstances, and underlying macroeconomic factors. As consumers continue to prioritize their digestive health and seek effective remedies, the market is expected to further expand in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)